Fatum Muhammad, Gyo Yi, Diana Prus, Laufer Neri, Simon Alex
Department of Obstetrics and Gynecology, Hadassah University Hospital, Ein Kerem, P.O. Box 12000, Jerusalem 91120, Israel.
J Assist Reprod Genet. 2006 Nov-Dec;23(11-12):407-12. doi: 10.1007/s10815-006-9089-2. Epub 2006 Dec 6.
Although high levels of estradiol are found in the follicular fluid, little is known about its necessity for adequate follicular growth, oocyte maturation and embryo development. Arimidex (anastrozole) is a potent aromatase inhibitor capable to induce an in-vivo milieu deprived of estradiol. This study uses a mouse model applying Arimidex to create an in-vivo system lacking of estradiol, in order to explore whether this gonadal steroid hormone is mandatory for folliculogenesis followed by normal fertilization and embryo development.
Experiment 1: Immature C57 Black female mice, aged 3-4 weeks were superovulated by 5 IU PMSG given intraperitoneally. A study group (9 mice) was concomitantly injected with 0.1 mg of Arimidex intraperitoneally given the morning day before PMSG, the morning day of PMSG injection and the following two days. The control group (8 mice) was similarly injected with normal saline. Estradiol (E2) and progesterone (P) serum levels were tested 48 hours after PMSG and the ovaries of each mouse blindly examined by a pathologist to evaluate follicular development. Experiment 2: 48 h after PMSG superovulation, hCG (7.5 IU) was injected intraperitoneally, followed by mating. The study group was treated with Arimidex 0.1 mg intraperitoneally daily from a day prior to PMSG injection to the day of sacrifice. The control group was treated similarly by normal saline. Forty-two hours after mating blood was withdrawn for E2 and P levels followed by tubal dissection. Embryos of 2-4 cells were cultured in-vitro and the development to the morula, blastocyst and hatching blastocyst stages were examined 24, 42, and 48 h later.
Experiment 1: A significant reduction of E2 levels was achieved in the Arimidex group in comparison to control group (126.3+/-104.8 and 1910+/-960 pmol/L, respectively; p < 0.0001). Nevertheless, the two groups did not differ by the mean number of follicles (27+/-9.5 and 30.4+/-13.0) or the distribution for antral (65% and 68.4%) and pre-antral (35% and 31.6%) follicles, respectively. Experiment 2: The reduction of estradiol during follicular phase did not hamper follicular development, in-vivo fertilization and in-vitro embryo development. Similar rates of embryo development to the morula stage (90.6% and 86%), blastocyst stage (86% and 89%) and hatching blastocyst (81% and 78%) were achieved in the Arimidex group and the control group, respectively.
Adequate folliculogenesis is independent of estrogen but is conditioned on gonadotropin stimulation. Moreover, depletion of estradiol in the vicinity of the oocyte did not impair its developmental potential, including its fertilization and development into morulae, blastocysts and hatching blastocysts.
尽管在卵泡液中发现了高水平的雌二醇,但对于其在卵泡充分生长、卵母细胞成熟和胚胎发育中的必要性知之甚少。阿那曲唑(瑞宁得)是一种强效芳香化酶抑制剂,能够诱导体内缺乏雌二醇的环境。本研究使用小鼠模型应用阿那曲唑创建一个缺乏雌二醇的体内系统,以探讨这种性腺甾体激素对于卵泡发生继而正常受精和胚胎发育是否必不可少。
实验1:3 - 4周龄的未成熟C57黑雌性小鼠通过腹腔注射5国际单位孕马血清促性腺激素(PMSG)进行超排卵。一个研究组(9只小鼠)在PMSG注射前一天早晨、PMSG注射当天早晨及随后两天腹腔内同时注射0.1毫克阿那曲唑。对照组(8只小鼠)同样注射生理盐水。PMSG注射48小时后检测血清雌二醇(E2)和孕酮(P)水平,并且由一名病理学家对每只小鼠的卵巢进行盲法检查以评估卵泡发育。实验2:PMSG超排卵48小时后,腹腔注射人绒毛膜促性腺激素(hCG,7.5国际单位),随后进行交配。研究组从PMSG注射前一天至处死当天每天腹腔注射0.1毫克阿那曲唑。对照组同样注射生理盐水。交配42小时后取血检测E2和P水平,随后进行输卵管解剖。将2 - 4细胞期的胚胎进行体外培养,并在24、42和48小时后检查其发育至桑葚胚、囊胚和孵化囊胚阶段的情况。
实验1:与对照组相比,阿那曲唑组的E2水平显著降低(分别为126.3±104.8和1910±960皮摩尔/升;p < 0.0001)。然而,两组在卵泡平均数量(分别为27±9.5和30.4±13.0)或窦状卵泡(分别为65%和68.4%)与窦前卵泡(分别为35%和31.6%)的分布上并无差异。实验2:卵泡期雌二醇的降低并未妨碍卵泡发育、体内受精和体外胚胎发育。阿那曲唑组和对照组分别达到了相似的胚胎发育至桑葚胚阶段(90.6%和86%)、囊胚阶段(86%和89%)和孵化囊胚阶段(81%和78%)的比率。
充分的卵泡发生不依赖于雌激素,而是以促性腺激素刺激为条件。此外,卵母细胞附近雌二醇的耗竭并未损害其发育潜能,包括其受精以及发育成桑葚胚、囊胚和孵化囊胚的能力。